DNTOX GmbH
|
Year Established:
2022 |
|
|
Website:
dntox.de |
|
|
Headquarters:
Düsseldorf, NRW, DE |
|
|
Company Type:
New Startup (0-1M TTM Revenue) |
|
|
Completed Requests:
1 |
|
|
Open Requests:
2 |
Toxicity testing and model development in vitro with a focus on developmental and adult neurotoxicity.
DNTOX GmbH uses human cell models and enables artificial intelligence-based screening with in-house developed software.
The in vitro test system is comprised of a set of multicellular test methods that are based on human neural progenitor cells (hNPCs) and human induced pluripotent stem cells (hiPSCs). These cells are cultivated as free-floating or plated and adherent 3D spheres as well as 2D monolayer cultures. Our cell models can be used to study several key neurodevelopmental and neuronal processes.
| Site | Badges | |
|---|---|---|
| DNTOX GmbH Gurlittstraße 53 Düsseldorf, NRW, 40223 Germany | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.